Hope and despair: a qualitative exploration of the experiences and impact of trial processes in a rehabilitation trial by Norris, Meriel et al.
RESEARCH Open Access
Hope and despair: a qualitative exploration
of the experiences and impact of trial
processes in a rehabilitation trial
Meriel Norris1* , Leon Poltawski2, Raff Calitri2, Anthony I. Shepherd3, Sarah G. Dean2 and on behalf of the ReTrain
Team
Abstract
Background: Unanticipated responses by research participants can influence randomised controlled trials (RCTs) in
multiple ways, many of which are poorly understood. This study used qualitative interviews as part of an embedded
process evaluation to explore the impact participants may have on the study, but also unintended impacts the study
may have on them.
Aim: The aim of the study was to explore participants’ experiences and the impact of trial involvement in a pilot RCT in
order to inform the designing and delivery of a definitive RCT.
Methods: In-depth interviews with 20 participants (10 in the intervention and 10 in the control group) enrolled in a
stroke rehabilitation pilot trial. A modified framework approach was used to analyse transcripts.
Results: Participation in the study was motivated partly by a desperation to receive further rehabilitation after discharge.
Responses to allocation to the control group included an increased commitment to self-treatment, and negative
psychological consequences were also described. Accounts of participants in both control and intervention groups
challenge the presumption that they were neutral, or in equipoise, regarding group allocation prior to consenting to
randomisation.
Conclusions: Considering and exploring participant and participation effects, particularly in the control group, highlights
numerous issues in the interpretation of trial studies, as well as the in ethics of RCTs more generally. While suggestions for
a definitive trial design are given, further research is required to investigate the significant implications these findings may
have for trial design, monitoring and funding.
Trial registration: ClinicalTrials.gov, NCT02429180. Registered on 29 April/2015.
Keywords: Trial design, Randomisation, Equipoise, Qualitative, Stroke, Rehabilitation
Background
Trial integrity is a key concern for clinical research to
ensure as much as possible that protocols are followed
and validity is enhanced. Randomised controlled trials
(RCTs) epitomise the drive to reduce bias and promote
internal validity in the hope that outcomes can be attrib-
uted to the intervention components. Despite ongoing
debate, RCTs (and systematic reviews of RCTs) are still
considered the pinnacle of primary clinical research [1],
and the inclusion of process evaluation assists in the abil-
ity to monitor and record the integrity of a complex trial
as is typical in rehabilitation research [2, 3]. Specifically,
qualitative data collection facilitates exploration of experi-
ences and factors not previously considered or known,
which could impact on the trial and can therefore inform
trial development. However, process evaluation also
potentially exposes contextual factors, including research
participation effects [4]. Within unblinded clinical trials,
as is common in rehabilitation, these effects may include
compensatory rivalry and resentful demoralisation, forms
of performance bias usually associated with control
groups. The former refers to an increase in performance
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in order to compete with the intervention group, the latter
a disengagement from performance due to frustration
with allocation. Both have been recorded in trials but are
considered poorly understood and inconsistent in presen-
tation [5]. Patient preference to allocation has also been
shown to influence trial outcomes, although clarity on the
extent of this influence is variable [6, 7].
Reasons for choosing to participate have also been
explored, with the suggestion that those volunteers less
driven by altruism may demonstrate stronger personal
influences on the study, for example, by compensatory
rivalry [4]. Other concerns include misunderstanding of
the trial processes, which can result in “therapeutic mis-
conception” where the research process is conflated with
therapeutic intentions [8]. Such individual interpreta-
tions of formal research processes and documentation
may result in behaviour change, but also fundamentally
challenge concepts of informed consent and the ethical
positioning of clinical trials [9]. The World Medical
Association [10] through the Declaration of Helsinki re-
quires that consent be based on appropriate information
regarding potential risks and benefits or participation,
and this would include the impact of trial processes such
as allocation. Some researchers have further suggested
that potential participants must also accept the process
of randomisation and do so from a position of equipoise
[11]. The latter point refers to an informed acceptance
and lack of preference for allocation to the intervention
or control group [12]. Indeed, Wade et al. ([13]:2025)
suggests that “randomisation is only ethical where evi-
dence of equipoise emerges”. However, research suggests
that such informed equipoise is often lacking in partici-
pants and the recruiting researchers [14–17].
McCambridge et al. [5] suggest that the there is a need
for more empirical work in order to elaborate the details
of research participation effects, and this paper is a re-
sponse to that call. Its aim is to explore the experience
and impact of involvement in a pilot RCT with a focus
on trial processes (e.g. recruitment, randomisation and
communication) rather than the intervention itself. Spe-
cific objectives are to explore the reasons for participa-
tion and the perceived impact of allocation on the
individual, with a view to informing the design and de-
livery of a definitive RCT.
Method
This qualitative study was embedded within an external
pilot RCT with parallel process evaluation [18, 19]. An ex-
ternal pilot RCT is not embedded in a full RCT (unlike an
internal RCT) and aims to test the main components in
preparation for a full RCT. The trial assessed the feasibility
and acceptability of a 12-week functional training
programme for community-dwelling adults with stroke.
All participants had been discharged from National Health
Service (NHS) physical rehabilitation programmes prior to
starting the trial. Group allocation was randomised using
a computer-generated algorithm, which considered time
since stroke and functional disability [19]. The control
group within the trial received treatment as usual and an
advice booklet about exercise after stroke [20]. Treatment
as usual varied between individuals and while we re-
quested that they did not participate in formal physical
rehabilitation, we did not prevent them from doing so.
Whether they did participate in other treatments was not
formally assessed. The intervention group received twice
weekly group training on functional rehabilitation, includ-
ing task-related practice, targeted strength training and
adaptations to tasks such as getting on and off the floor.
These were based on the action for rehabilitation from
neurological injury (ARNI) principles [21] and delivered
by ARNI-trained fitness professionals. This was comple-
mented with additional targeted homework and goal set-
ting to enhance self-management. The main outcomes
focused on feasibility, fidelity and acceptability. Functional
outcomes included a suite of measures primarily River-
mead Mobility Index, Timed Up and Go, modified
Patient-Specific Functional Scale and objective physical
activity monitoring through wrist-worn accelerometers,
supplemented with a diary. A range of other secondary
outcomes were also included [19]. The process evaluation
was designed to examine fidelity to the defined
programme in addition to feasibility and acceptability as
recommended for complex rehabilitation interventions
[3]. As part of the process evaluation a purposive sample
of participants in both the intervention group and the
control group were interviewed at the end of the interven-
tion period of the trial (approximately 6–7months post
randomisation) in order to ascertain their experiences of
the trial in general, including the trial processes. The data
in this paper are drawn from these interviews, which
explored both specific experiences of trial involvement
and perceived response to the intervention (considered in
detail a separate paper [22]).
A qualitative approach to this aspect of the process
evaluation was taken because of the necessary focus on
the participants’ experience [23]. Methodologically the
study drew on constructionist and phenomenological
traditions in order to represent the influence of the con-
text of the training group structure while remaining
focused on the experiences of the individuals themselves
(see [22] for further details). A sampling frame was cre-
ated based on characteristics potentially influencing
process and outcome, including gender (male/female),
age (younger, ≤ 60 years/older, 61+ years), cohort (1a, 2
or 3), level of disability post stroke (as measured by the
modified Rankin Scale (MRS) 0–2, mild/3–4, moderate),
self-reported exercise proclivities pre stroke (exerciser/
non-exerciser), time since stroke (more or less than 12
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months) and, for the intervention group, participation
level in training (high or low based on attendance). The
pilot trial had 45 participants randomised between the
intervention and control groups, and 10 in each group
were invited and subsequently consented to interview.
This number was selected as it met the needs of the
sampling frame (i.e. all criteria were represented), was
feasible and avoided unnecessary participant burden.
The trial ran in four cohorts relating to different locations
and recruitment periods. All individuals who at the point of
consent to the main trial had agreed to be contacted to
consider taking part in an interview were entered in the
sampling frame (43 participants). Ten participants each
from the control and intervention groups were purposefully
sampled, ensuring that all sampling criteria were met. The
trial manager (RC) contacted potential interviewees and in-
vited them to interview. On agreeing to participate, contact
details were passed onto the interviewer (LP), who arranged
the visit.
Semi-structured one-to-one interviews were conducted
in the location of participants’ choice (their home for all)
by an experienced qualitative researcher. The researcher
was associated with the trial and therefore had knowledge
of both the trial and intervention but was not involved
with recruitment, intervention delivery or assessment. The
interviews followed topic guides, which had been previ-
ously developed through reference to the literature and
discussions within the research team including representa-
tion from stroke survivors. This paper specifically focuses
on questions that related to study involvement rather than
experience of the intervention itself (see Table 1 for ex-
ample questions).
All interviews were audio-recorded and transcribed
verbatim. The transcripts were analysed by an experi-
enced qualitative researcher (MN) who was aware of the
content of the intervention but not involved in its deliv-
ery or assessment. A framework analysis [24] was under-
taken to explore the data using both the deductive and
inductive approaches. Deductive codes were applied to
aspects that were specifically asked about in the topic
guide, e.g. acceptability of communication with the re-
search team; however, the majority of codes and all
themes were inductive. This involved several phases as
illustrated in Fig. 1.
Additional negative case analysis, in which reference
to views opposed to emerging themes are specifically
considered, was undertaken between the labelling and
charting phases. The initial analysis was completed inde-
pendently for each group of participants (intervention
and control) but combined at the labelling phase for
aspects relating to trial involvement. All data collection
and analysis were completed blind to the results of the
study itself, with additional information about the quan-
titative results of the study added later.
Discussions were held with the other members of the
trial team (SD/RC/LP) during analysis and writing. These
discussions were not deemed to be a validation process,
but rather an opportunity for critical reflection on the
depth of the analysis and appropriateness of interpreta-
tions drawn [25].
Ethical review was conducted and approved by NRES
Committee South West – Cornwall & Plymouth (REC
ref. 15/SW/04) and participants were given further infor-
mation and provided further written consent for the
interview phase of the study.
Results
Characteristics of the interviewees are given in Table 2.
These include 10 participants from the intervention group
(6 male, mean 44months since stroke - range 2–120
months, MRS 2–3, mean age 72 years - range 56–91 years)
and 10 from the control group (6 male, mean 65months
since stroke - range 5–204months since stroke, MRS 1–3,
mean age 72 years - range 48–89 years). This is represen-
tative of the participants in general and of a chronic
community-dwelling population of stroke survivors, and
met all our sampling frame criteria. The interviews lasted
on average 42min (range 12–78 min).
This section presents the two main themes derived from
the data: the subsection “An offer too good to refuse” ex-
plores the reasons participants gave for volunteering for the
study. The combined drivers of gratitude, desperation, and
acceptance of professional guidance highlight particular
ethical concerns. The subsection “The nature of control”
examines the responses to group allocation and how partic-
ipants experienced participation in the research processes.
Here, primacy is given to the experience of control-group
allocation, due to the strength and diversity of their
responses and scarcity of literature in this area. In line with
the qualitative approach, interpretation of the participants’
words is presented alongside the quotations. In the presen-
tation of the themes, study ID is used for supporting quota-
tions with basic demographic descriptors (gender_ age),
group allocation and transcript line number.
An offer to good to refuse
Participants expressed multiple motivations for their in-
volvement in their study, resulting in two sub-themes;
Table 1 Indicative interview questions
Example question
Why did you volunteer to take part in this study?
Did you have any concerns or fears about taking part?
What did you think was involved in the programme before you took
part?
What did you think about the fact that you could have been put into
either the group receiving supervised training or the group that
received an exercise leaflet?
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Fig. 1 Phases in Framework Analysis [24]
Table 2 Participant characteristics
Trial arm Participant
number
Cohort Time since stroke
(months)
MRS* Age Sex Programme attendance
categorisation
Pre stroke exercise
tendencies**
Control 2 1a 36 2 77 F n/a Exerciser
Control 3 1a 40 3 81 M n/a Non-exerciser
Control 7 1a 5 3 73 M n/a Exerciser
Control 8 2 54 2 64 M n/a Exerciser
Control 12 2 11 3 89 M n/a Non-exerciser
Control 14 2 53 3 48 M n/a Non-Exerciser
Control 19 2 30 2 63 F n/a Non-exerciser
Control 35 3 204 2 82 F n/a Exerciser
Control 39 3 96 2 70 F n/a Non-exerciser
Control 41 3 120 1 74 M n/a Non-exerciser
Intervention 4 1a 36 3 64 M High Non-exerciser
Intervention 5 2 4 3 73 M Low Non-exerciser
Intervention 6 1a 42 3 91 M High Non-exerciser
Intervention 9 2 18 3 56 F High Exerciser
Intervention 16 1a 2 3 89 M High Non-exerciser
Intervention 22 2 120 2 77 M Low Exerciser
Intervention 25 2 33 3 80 F High Non-exerciser
Intervention 30 2 13 2 59 M High Exerciser
Intervention 32 3 84 2 67 F Low Non-exerciser
intervention 43 3 90 2 68 F Low Exerciser
*MRS =Modified Ranking Scale (measuring level of disability - higher value indicates greater disability)
**Attendance categorisation: the amount of intervention received and engaged with by the participant, dichotomised into high (>60% attendance) versus low
(<60% attendance)
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Doing it because of others, and “I would have done any-
thing”. Combined, they suggest influences that challenge
concepts of equipoise in decision-making when volun-
teering to take part in a RCT.
Doing it because of others
It was evident in the transcripts that a number of the par-
ticipants joined the study due to past or ongoing experi-
ences and advice. For example, one was motivated by the
recommendation of their general practitioner (GP) with
whom they had a long and trusted relationship:
I had a letter from the GP … so she said ‘I wonder if
you would like to, you know go for it?’ … I thought
‘right well she sent me the letter so she must think
well there could be some good to come out of it.
(32,F/82 CG:205–209, 262).
Another suggested that the fact the study was funded
by the Stroke Association gave it a credibility that they
were willing to trust. A more general influence was pre-
vious care they had received in their stroke journey, as
participant 6 describes:
I wanted to say thank you for all the help I had been
given … everybody has been so kind and helpful (6:M/
91 IG:47, 78).
The participant continues with a description of the
lack of expectation he had for his own personal benefit,
describing participation as an act of giving and contribu-
tion. In this case the gratitude was directed primarily at
the individuals who had introduced him to the study
and not his formal NHS care.
While past kindnesses were referred to as a key motiv-
ation, future projections were also inferred. Participants
demonstrated an understanding that the research endeav-
our was an investment in future therapeutic benefits,
mainly for other people. Being part of the process of
developing a better future for other stroke survivors was
an important element in their decision-making and some-
thing they found rewarding:
I think that I wanted to help, because I had the stroke
and I wanted to be part of the team that could help. It
was a new thing that they were starting, a new study
and I am a bit … I thought that if I can help in these
situations, you know I am willing and I am up for it.
(30: M/59 IG:124–127).
I felt it would only benefit other people … having done
research for the medical school in the hope, helping other
people ... And I thought well if it helped other people
with stroke then I would go for it (7: M/73 CG:283–289).
This reference to research and benefit to others rather
than yourself was only directly expressed by those in the
control group (participants 3, 7, 30, 35, 39). This may
suggest that its emphasis is heightened retrospectively in
the absence of their own individual therapeutic benefit.
A third aspect of this sub-theme was the process of
participation selection itself. One participant described
how being selected and clearing the screening process
demonstrated that they had been “chosen”. As such that
selection endowed a gratitude that they intended to
honour through participation in the study:
I had a clear mind. I thought ‘right go for it,
whatever they, I have been offered’. I am very
grateful and that I have been chosen to take part.
(43: F/68 IG 151–152).
This last aspect was unsurprisingly from a participant
in the intervention group. The potential implications of
not “being chosen” are discussed later.
“I would have done anything”
In contrast to the altruistic position described above was
one that was firmly situated around personal drivers and
the expectation that inclusion would impact positively
on their life. This was the most common reason for par-
ticipation, although most strongly articulated by partici-
pants in the intervention group:
I just want to do anything. Anything to get better; to
better myself … if someone came along tomorrow and
said there’s a new exercise on the moon, I would be
the first one there. (4: M/64 IG:91–93).
Because I would have done anything … to be able to
get back to a bit of normal life again you know.
Because this is not my life sitting like this no way. (25:
F/80 IG:229–231).
Within these narratives was a strong sense of desper-
ation for help, a willingness to try anything. While partici-
pant 25 (F/80 IG) suggests that this motivation/
desperation is driven by a desire to change a current status
that they consider incompatible with their description of
life, others looked to external factors. For example, partici-
pant 30 (M/59 IG) discussed a conversation he had with
other participants, which reflected on their previous re-
habilitation care:
When I left the physio, I thought is that it now … no
further to continue and actually it was one of the
main points that many people brought up. One of the
guys said ‘it’s as if we are now on the scrap heap,
that’s the end of it’ (30: M/59 IG:191–198).
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It would appear from these narratives as if the com-
bination of dissatisfaction with their current status and
the sense that they had been neglected or deserted by
their formal rehabilitation guides left the participants
desperately searching for other opportunities.
Linked with this was the expressed view that some im-
provement was expected as a result of inclusion in the
study. For most this was a vague expectation that it might
“make a difference” (19: F/63 CG:270) or “I thought it may
help me” (25: F/80 IG:229). For others, more specific ex-
pectations were expressed. For example, participant 41 (M/
74 CG) said he did not think the exercises he was currently
doing were appropriate or the most beneficial and he
hoped that this intervention might give him the “right sort
of exercises”. Participant 6 (M/91 IG) in contrast was per-
suaded that the cardiovascular benefits were an important
factor and were key to his decision to participate.
Overall this theme suggests complex and various influ-
ences on the motivation to participate in the study. Dif-
ferences between the control and intervention group are
noted, particularly in relation to doing it because of
others or expected personal gain, respectively.
The nature of control
This theme explores the participants’ responses to their al-
location and their experiences of the trial processes. It is
perhaps unsurprising that the narratives from the control
group contained a richer engagement with this line of
enquiry, and offer an array of important insights into the
experience of being the “ones who lost out” and critically
the impact of that perceived “de-selection” on the behav-
iour of individuals. This section presents two sub-themes
in the subsections “Acceptance but potentially cast adrift”,
through which the necessity of research, personal circum-
stance and contact in the research are explored, and “De-
termination to change”, where the allocation process itself
becomes an active part of an intervention.
Acceptance but potentially cast adrift
Allocation was met with positivity in the intervention
group. Participants wanted to “open their eyes to some-
thing new” (4: M/64 IG:1193) and “be chosen to do the
proper thing” (6: M/91 IG:905), and this gave them the
opportunity to achieve that:
Well I was a bit worried I wasn’t going to get into it
you know. I thought I was you know, I’m going to
miss out … but I didn’t so I got the right one (5: M/
73 IG:814–817).
All indicated that allocation to the control group
would have disappointed them, with four participants (4,
5,22,43) suggesting they may have dropped out of the
trial as there would be little personal advantage with
continuing. For six of the participants in the control
group, their allocation was not a significant concern.
They had understood the control trial process and the
requirement for some people to end up not having the
intervention. Participant 35 describes the acceptance of
this allocation clearly:
I accepted that you can’t really do something like this
without actually having a control group can you? ... I
was interested in what I could get out of it, but it
didn’t bother me terribly that I didn’t get in. (35:F/82
CG:312–321).
Not all of the participants were as clear about the role
and need of the control group, but nevertheless they ac-
cepted their allocation. In some cases, such as partici-
pants 12 and 35, they were somewhat relieved as they
either perceived exercise to not really be their thing or
were concerned by the burden of the twice weekly class
obligation. Such narratives hint at the possibility that
allocation to the intervention group may have resulted
in unwilling participants or poor attendance.
In contrast, four participants described quite a nega-
tive reaction to being in the control group and indeed
one dropped out of the study, citing unhappiness in their
allocation as the reason. Perhaps unsurprisingly, disap-
pointment was the most commonly expressed emotion.
“Yeah, I was disappointed … I should think everybody
was, wasn’t they?” (19: F/63 CG:439–443).
I appreciated that it was a fifty/fifty chance of help
and I felt very guilty that I didn’t sort of get myself
together to explore. But I did feel quite disappointed
to be honest. (2:F/77 CG:165–167).
This quote from participant 2 hints at the implication
of that disappointment. Her reference to guilt suggests a
self-expectation that when she was recruited into the
control group this should have prompted her to explore
other opportunities for rehabilitation, an expectation she
was unable to enact. This participant had a history of
depression and her narrative continues to suggest that the
fact that she was unable to change her physical condition
contributed to a recent self-reported deterioration in her
mental health and restarting of associated medication.
While not referring to depression, participant 19 de-
scribes a sense of being a little invisible as illustrated in
this passage, which followed a discussion about whether
the control group should be given more exercises to do.
Well it might have made me feel like I wasn’t just cast
adrift … I think especially probably for the people in
the control group because they’re not going out to
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classes and doing anything. To make them feel like
they’re contribution is worth having. And that you’re
not just abandoned (19: F/63 CG:993–1007).
This sense of abandonment and being “cast-adrift” is
noted despite the fact that all participants commented
that they were satisfied with the communication with
the research team over the research period.
It is perhaps relevant to note that many of the control
group commented on the practical irrelevance of the
usual-care booklet that they were given. With the excep-
tion of participant 3, all were aware of the booklet in
some form or other and most remembered reading it.
However, the vast majority agreed that if they remem-
bered the content at all, it was too generalised, covered
ground they already knew and therefore did not impact
on their activities.
I thought it would be more specific to stroke. I think I
thought it would tell me something I didn’t already
know maybe or just set me certain tasks that I could
tick off. (2: F/77 CG:177–179).
Interviewer (Int): Do you remember getting that
leaflet?
Participant (Part): Vaguely yes.
Int: Did you look at it?
Part: I must have done.
Int: Did it make any difference receiving that or read-
ing it?
Part: Hmmm, I don’t think so. (12: M/89 CG: 524–
534).
In contrast to this generally perceived lack of impact of
the leaflet, a few participants did like it. Three participants
(41, 14 and 8) all commented positively on the content in
a general fashion. However, only one indicated that read-
ing the leaflet made any difference to their actual activity.
The leaflet was given as part of usual care and was not
designed to change behaviour particularly. As a result,
the fact that it does not appear to have done so is not a
major concern. However, its presence but lack of utility
does have the potential to create frustration if expecta-
tions are inadvertently raised in this group of individuals
who are desperate for their current condition to change.
Determination to change
This final sub-theme focuses on the actions taken by
some participants in apparent response to their alloca-
tion to the control group. Despite the general disap-
pointment of allocation to the control, most participants
accepted their position and reported continuing activ-
ities as normal. However, for 4 of the 10 interviewees,
allocation to the control group was a prompt for action.
The nature of that prompt differed between participants.
For participant 3, inclusion in the study became an indi-
cation that they were no longer invisible in a world that
seemed not to notice her condition. As a result, this
changed her response to her current situation.
It is nice to know that somebody cares … and it [the
study] made a difference. Oh yes of course it did yeah
… it gives you a little bit of hope. A bit of
encouragement … I am determined to keep going (3:
M/81 CG 298–327).
She goes on to discuss her commitment to the gym and
also regularly completing exercises she had previously
been given from the hospital. This sense of keeping going
and action despite allocation to control was shared by par-
ticipant 8. Participants 7 and 14, however, had a more ac-
tive response to their allocation. Participant 7 immediately
joined a gym and reported increasing their activity levels,
and participant 14 and their carer were quite robust in
their response.
Well bugger them; we are going to prove them that
you don’t need expensive trainers … I would describe
myself as slightly bloody minded and stubborn and if
it doesn’t go my way you know I will do what I can to
prove everyone wrong. (14 carer:1158–9/ 1181–1186).
It was like blooming heck, all this for … Hold on.
Alright, come on we’ll go and get that done. (14: M/
48 CG:1192–1193).
They set goals and described an active regime of spe-
cific exercises and more general physical activity in order
to create their own rehabilitation programme. They later
described some of the benefits both in movement and
everyday life that they had perceived as a response.
Such narratives are essential to capture as they challenge
the idea that the control group simply continue with usual
care, and in this specific case, the narrative gives support
to concepts of compensatory behaviour change. If the
involvement in the study itself creates an environment of
intervention, then the gap between control and interven-
tion group is at best blurred and narrowed at worst,
potentially undermining the purpose of a controlled trial.
Discussion
This study aimed to explore the experience and the poten-
tial impact of participation in a stroke rehabilitation trial. In
relation to the specific objectives, the reasons for participa-
tion were found to be complex, and in some cases influ-
enced the individual’s trial experience. Group allocation
was viewed in different ways by participants, but allocation
to the control group may have negatively impacted some
individuals, and may also have undermined control group
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fidelity in the study. More specific discussion and compari-
son with the literature is given below illuminating the
participant effects in the trial. This is followed by recom-
mendations, based on our findings to help inform the
design and delivery of a definitive RCT.
The first issue raised through these interviews is the
complexity of ethics within consent for this trial. While
altruism was expressed as a motivator, which is consistent
with other studies [26, 27] and was prominent in the narra-
tives of the control group [16], it was not the only reason
cited for participation. Expectations of direct personal bene-
fit of inclusion coincided with apparent endorsement from
key stakeholders, in this case the research funder and the
clinicians who were involved in potential participant identi-
fication. This combination may lead to assumptions of
therapeutic benefit of participation, which aligns with con-
cerns of therapeutic misconception [8] and this has been
discussed in other studies [5, 27]. These influences are
important to consider as they demonstrate the potential
power of these stakeholders regarding the project and the
projection that they are also endorsing its content. It re-
emphasises the importance of these figures being mindful
of their role as gate-keepers and guides in the decisions
potential participants may take. However, removing this en-
dorsement could undermine recruitment rates and it may
rather be for researchers, who are obtaining the consent, to
be more vigilant in ensuring participant equipoise at the
time of recruitment.
The apparent focus on the positive potential for partici-
pation links rather uncomfortably with the expressed
desire or desperation for improvement. It is beholden on
researchers to ensure that participants have considered
the personal implications of taking part in the study in a
balanced and informed fashion before consenting,
although their capacity and desire to do so has been ques-
tioned for some time [8, 13]. However, it is less clear how
this can be appropriately negotiated and ensured when
potential participants are willing to try anything, particu-
larly anything apparently endorsed by trusted sources.
Furthermore, evidence suggests that participants do not
fully engage with participation information sheets [16, 28],
which implies the need for an even stronger emphasis on
the ethical imperative for the recruiting researcher to
establish equipoise in their personal interactions with po-
tential participants [14, 29].
Ethically, participants in a trial such as this are described
as vulnerable, but the nature of that vulnerability is rarely
articulated in detail. These narratives suggest that an indi-
vidual’s very desire/desperation to participate in a trial
may render them vulnerable to suggestion, which in turn
disrupts the equipoise deemed essential for ethical
consent-gaining and hence for effective randomisation
[10]. Such imbalances in decision-making parallel those
seen in treatment decision-making in general healthcare
[30, 31] and other clinical trials [16, 17], and create an eth-
ical challenge for trial managers and recruitment
personnel worthy of further enquiry.
A further ethical concern raised in these interviews was
the potential implication of perceived rejection [16]. The
narratives from the control group indicated a sense of
being forgotten, or set aside as the “unchosen” despite
their regular contact with the research team. It is particu-
larly relevant that these narratives of abandonment mirror
those of stroke survivors when describing their experience
of rehabilitation more generally, creating a double loss
[32, 33]. From an ethical perspective the most concerning
was the potential implications for the mental health of
participants, particularly pertinent given the high rates of
depression in people post stroke [34]. Therapeutic expec-
tations, heightened through recruitment but later
thwarted through allocation to the control group, may
exacerbate feelings of abandonment and hopelessness
already experienced by some stroke survivors when their
rehabilitation ends. It is possible to hypothesise that this
impact was exacerbated by the use of a non-active control
and other studies have reported participants feeling “swin-
dled” when allocated to the control group [35]. However,
studies using active controls have also illustrated concerns
with treatment preference and acceptance of equipoise in
the randomisation process [29].
All clinical trials have processes in place to record ad-
verse events during the course of a trial. These accounts
highlight the importance of monitoring, recording and (if
appropriate) acting on psychological as well as physical
events that may occur during a trial [16]. They also chal-
lenge researchers to consider inclusion and exclusion
criteria of trials as well as the nature of risks identified
during participant screening and the pre-consent process.
While resentful demoralisation has been considered as a
potential consequence of the randomisation process,
detailed links between this and legitimate concerns that
demoralisation may have significant mental health impli-
cations require further consideration. Furthermore, to
date it is unknown to what level the risk of such mental
health concerns is highlighted in participant informa-
tion for physical rehabilitation trials, and such a review
would be worthwhile. Indeed, this finding suggests that
explicit reference to the potential psychological impact
of being allocated to an inactive control could add to
the risks identified in the participation information
sheet. It might also be explored during the consenting
process. Such measures may reduce recruitment and
would therefore require sensitive application and a bal-
ance in judgement regarding how much this risk is
raised with potential recruits. However, concerns with
recruitment targets should not outweigh the transpar-
ency required for meeting the principles of informed
consent.
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A further issue identified in this study is the potential im-
pact of compensatory behaviour change on trial outcomes.
If the conclusions of trials are to be based on the changes
in quantitative outcome measures, then it is apparent that
an unmonitored active control may interfere with the
capacity for any change to be evident or attributable to the
intervention itself. The combination of narrative and
concomitant reported change in physical outcomes for one
participant in this pilot study in particular indicates that
this may be the case. If so, recruitment to the trial itself
can become an active intervention. While a study of the
impact of participation in RCTs found no evidence of
benefit or harm to RCT participants, compared to those
involved in cohort (uncontrolled) studies of similar inter-
vention [36], an impact of group allocation has been sug-
gested previously [5], but has rarely been fully explored [4].
Such insights highlight the need to understand partici-
pants’ decision-making processes and action post random-
isation, as well as the impact on behaviour of information
given pre-consent. Indeed, McCambridge et al. ([5]:246)
suggest that “fine grained attention to how participants
react to what they are asked to do in research, and how this
may impact on study outcomes, is needed” and our study
supports that view. It also demonstrates the value of con-
trol group interviews and monitoring control group fidelity
as part of process evaluation in order to understand and
explain the trial results obtained. Such evaluation is not
mentioned in reporting guidelines for pilot studies such as
the Template for intervention description and replication
(TIDieR), or the Consolidated standards of reporting trials
(CONSORT) extension for pilot and feasibility studies.
Funders and reviewers of pilot and feasibility trials may
wish to pay closer consideration to these issues in future
proposals.
In summary, this study has highlighted a number of
areas that could impact on the ethical conduct of a re-
habilitation trial and on the appropriate interpretation of
outcomes. A number of suggestions have been made
that may address these concerns and are summarised in
Table 3. These will be considered in the development of
the definitive ReTrain trial, but may also have relevance
for other rehabilitation trials more broadly.
Limitations
The interviews were conducted at the end of the trial
and therefore the experiences of allocation were retro-
spective. This, and the outcomes associated with partic-
ipants’ allocation, may have impacted on the nature of
the narratives. This is particularly the case with group
allocation where initial thoughts are likely to have
evolved over time and the subsequent experience of
being in either the intervention or control group for
several months. It is also important to acknowledge
that these data were only from a sub-sample of the par-
ticipants in the study. While the sampling frame target
was achieved and a range of views was evident, it is
possible that other insights were missed. Data satur-
ation was not formally assessed in this study but there
was sufficient repetition of ideas to suggest that key
issues were captured.
The primary analysis was not completed by the inter-
viewer. This has certain disadvantages as nuances in ges-
ture and meaning may be lost. However, the inclusion of
the interviewer in subsequent discussion of the analysis,
as well as critical reflective discussions, negative case
analysis and transparent analytical processes, helped en-
sure the rigour of the study and results presented.
Table 3 Concerns and recommendations for informing the design and delivery of a definitive RCT
Concerns Recommendations
Motivation for taking part Recruiting staff to recognise that not all people are motivated by altruism
Endorsement by stakeholders (clinicians and funders) Required for identifying potential participants and starting the recruitment process;
training for Participant Identification Centre (PIC) clinicians to be aware of their “gate-
keeping” role
Desperation for improvement PIC clinicians and recruiting researchers to ensure potential participants are informed
and understand the need for equipoise through careful reiteration of the current state
of knowledge and potential risks as well as benefits of participation with the aim to
facilitate appropriate decision-making
Abandoned to the control group Consider more active forms of comparator, or waiting list control. Careful inclusion of
interviews to ascertain group preference
Negative effects on mental health (if allocated to the
control)
PIC clinicians and recruiting researchers to be aware of the vulnerability of potential
participants; more active monitoring of adverse events in the control group, ensure
mental health deterioration included in monitoring and reporting of adverse events
Compensatory behaviour change (control group participants
seek their own version of the intervention)
Consider more active comparator or waiting list control; better monitoring of control
group activity. Consider alternative trial designs such as rigorous pragmatic or
observational cohort studies.
Recommend process evaluations always include control group participants and
update reporting check lists to this effect
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Conclusion
This paper has argued that participant effects within a
rehabilitation pilot randomised controlled trial raise con-
cerns about its ethical conduct and the interpretation of
its results. It suggests that motivations to take part, and
particularly the desperation for improvement in their
condition, may create vulnerability in some study partic-
ipants. This can hamper informed decision-making and
result in undesirable impacts on members of the control
group. Without adequate consideration of these effects,
trials run the risk of undermining the health and well-
being of some participants, and of drawing erroneous
conclusions about group differences in effects.
We conclude that in the design and delivery of a future
trial, increased attention should be accorded to these
effects, and that process evaluation should give detailed
consideration to the behaviours and experiences of partici-
pants in the control group. We further propose that such
measures may help other rehabilitation trials to protect
the wellbeing of participants and may enhance the cred-
ibility of their findings.
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